Literature DB >> 7681040

Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.

E Roilides1, K Uhlig, D Venzon, P A Pizzo, T J Walsh.   

Abstract

Invasive aspergillosis is a serious fungal infection caused by the proliferation and invasion of Aspergillus hyphae in tissue. Neutrophils (PMNs) are the most important line of defense against Aspergillus hyphae. To investigate the role of granulocyte colony-stimulating factor (G-CSF) and gamma interferon (IFN-gamma) against Aspergillus fumigatus, we studied the effects of the two cytokines on the oxidative burst and the capacity of normal human PMNs to damage hyphae of the organism. G-CSF enhanced PMN oxidative burst measured as superoxide anion (O2-) production in response to N-formylmethionyl leucyl phenylalanine, serum opsonized hyphae, and nonopsonized hyphae by 75, 37, and 24%, respectively, compared with control PMNs (P < 0.015). IFN-gamma also induced increases of 52, 71, and 96%, respectively, in response to the same stimuli (P < 0.006). In addition, the capacity of PMNs to damage hyphae as measured by the 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MMT) colorimetric metabolic assay was significantly enhanced by G-CSF and IFN-gamma (P < 0.01 and < 0.05, respectively). The enhancement was achieved irrespective of serum opsonization of the hyphae, suggesting upregulatory actions of the two cytokines on signal pathways specific for opsonized and nonopsonized hyphae. The combination of the two cytokines exhibited an additive effect at the higher concentrations compared with the effects of the cytokines alone (P < 0.05). Pretreatment of PMNs with protein synthesis inhibitors showed that IFN-gamma activates PMN function through transcriptional regulation, whereas the effect of G-CSF does not require new proteins. These in vitro effects suggest modulatory roles for G-CSF and IFN-gamma in the host defense against Aspergillus hyphae irrespective of serum opsonization and a potential utility of the cytokines as adjuncts for the prevention and possible treatment of invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681040      PMCID: PMC281347          DOI: 10.1128/iai.61.4.1185-1193.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma.

Authors:  J Fleischmann; B Wu-Hsieh; D H Howard
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

2.  Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils.

Authors:  A M Buckle; Y Jayaram; N Hogg
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

Review 3.  Invasive pulmonary aspergillosis in patients with neoplastic diseases.

Authors:  T J Walsh
Journal:  Semin Respir Infect       Date:  1990-06

4.  Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.

Authors:  G Morstyn; G J Lieschke; W Sheridan; J Layton; J Cebon; R M Fox
Journal:  Semin Hematol       Date:  1989-04       Impact factor: 3.851

5.  Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation.

Authors:  W P Sheridan; G Morstyn; M Wolf; A Dodds; J Lusk; D Maher; J E Layton; M D Green; L Souza; R M Fox
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

6.  Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor.

Authors:  E Roilides; S Mertins; J Eddy; T J Walsh; P A Pizzo; M Rubin
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

7.  Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.

Authors:  M S Cairo; D Mauss; S Kommareddy; K Norris; C van de Ven; H Modanlou
Journal:  Pediatr Res       Date:  1990-06       Impact factor: 3.756

8.  Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.

Authors:  J H Rex; J E Bennett; J I Gallin; H L Malech; D A Melnick
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

9.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

10.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  48 in total

1.  Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.

Authors:  J E Wang; A Warris; E A Ellingsen; P F Jørgensen; T H Flo; T Espevik; R Solberg; P E Verweij; A O Aasen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Effects of Aspergillus fumigatus culture filtrate on antifungal activity of human phagocytes in vitro.

Authors:  T Murayama; R Amitani; Y Ikegami; R Kawanami; W J Lee; R Nawada
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

3.  Intubation practice on cadavers should stop.

Authors:  Alison Tonks
Journal:  BMJ       Date:  1992-08-08

4.  Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.

Authors:  Stefanie S V Henriet; Peter W M Hermans; Paul E Verweij; Elles Simonetti; Steven M Holland; Janyce A Sugui; Kyung J Kwon-Chung; Adilia Warris
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

5.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 6.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.

Authors:  Stacy J Park; Molly A Hughes; Marie Burdick; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Immunomodulation Therapy for Invasive Aspergillosis: Discussion on Myeloid Growth Factors, Recombinant Cytokines, and Antifungal Drug Immune Modulation.

Authors:  Amar Safdar
Journal:  Curr Fungal Infect Rep       Date:  2010-03

9.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.

Authors:  B Jahn; E Martin; A Stueben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.